An inhibin B and estrogen-secreting adrenocortical carcinoma leading to selective FSH suppression

Hormone Research

Volumn 67, Issue 1, 2007, Pages 7-11

  Barisson Villares Fragoso, Maria Candida ^a   Fonte Kohek, Maria Beatriz ^b   Matsunaga Martin, Regina ^a   Latronico, Ana Claudia ^a   Lucon, Antonio Marmo ^a   Zerbini, Maria Claudia ^a   Longui, Carlos Alberto ^c   Mendonca, Berenice Bilharinho ^a   Domenice, Sorahia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Adrenocortical carcinoma; Estrogen; FSH; Inhibin B

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN; HORMONE ANTIBODY; INHIBIN B; LUTEINIZING HORMONE; MITOTANE; TESTOSTERONE;

ABDOMINAL PAIN; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; BREAST TUMOR; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; GONADORELIN RELEASE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIBIDO DISORDER; LIPOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL CAVITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; STAINING; TIME OF DEATH; TUMOR CELL; TUMOR RECURRENCE;

EID: 33846974054     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095806     Document Type: Article

References (19)

1. Dackiw AP, Lee JE, Gagel RF, Evans DB: Adrenal cortical carcinoma. World J Surg 2001;25:914-926.
2. Ng L, Libertino JM: Adrecortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5-11.
3. Wajchenberg B, Albergaria PM, Mendonca BB, Latronico AC, Campos Carneiro P, Alves VA, Zerbini MC, Liberman B, Carlos Gomes G, Kirschner MA: Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000;88:711-736.
4. Tauchmanova L, Colao A, Marzano LA, Sparano L Camera L, Rossi A: Adrenocortical carcinomas: twelve years prospective experience. World J Surg 2004;28:896-903.
5. Gabriloven JL, Sharma DC, Wotiz HH, Dorfman RI: Feminizing adrenocotical tumors in the male: a review of 52 cases including a case report. Medicine 1965;44:37-79.
6. Mendonca BB, Lucon AM, Menezes CAV, Saldanha LB, Latronico AC, Zerbini MC, Madureira G, Domenice S, Albergaria MAP, Camargo MHA, Halpern A, Liberman B, Arnhold IJP, Bloise W, Andriolo A, Nicolau W, Silva FAQ, Wroclaski E, Arap S, Wajchenberg BL: Clinical hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. J Urol 1995;154:2004-2009.
7. Ribeiro RC, Michalkiewez EL, Figueiredo BC, DeLacerda L, Sandrini F, Pianovsky MD, Sampaio G, Sandrini S: Adrenocortical tumors in children. Braz J Med Biol Res 2000;33:1225-1234.
8. Latronico AC, Pinto EM, Domenice S, Fragoso MCBV, Martin RM, Zerbini MC, Lucon AM, Mendonca BB: An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001;86:4970-4973.
9. Young J, Bulun SE, Agarwal V, Couzinet B, Mendelson CR, Simpson ER, Schaison G: Aromatase expression in a feminizing adrenocortical tumor. J Clin Endocrinol Metab 1996;81:3173-3176.
10. Kuhn JM, Lefebvre H, Duparc C, Pellerin A, Luton JP, Strauch G: Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion. J Clin Endocrinol Metab 2002;87:2367-2375.
11. Weiss LM, Medeiros LJ, Vickery ALJ: Pathologic features of prognosis significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-206.
12. Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M: Discerning malignancy in adrenocortical tumors: are molecular markers useful. Eur J Endocrinol 2001;145:335-341.
13. Risbridger GP, Schmitt JF, Robertson DM: Activins and inhibins in endocrine and other tumors. Endocr Rev 2001;22:836-858.
14. De Jong FH, Grootenhuis AJ, Steenbergen J: Inhibin immunoreactivity in gonadal and non-gonadal tumors. J Steroid Biochem Mol Biol 1990;37:863-866.
15. Arola J, Liu J, Heikkila P, Voutilainen R, Kahri A: Expression of inhibin α in the human adrenal gland and in adrenocortical tumors. Endocr Rev 1998;24:865-867.
16. Munro LM, Kennedy A, McNicol AM: The expression of inhibin\activin subunits in the human adrenal cortex and its tumors. J Endocrinol 1999;161:341-347.
17. Vänttinen T, Kuulasmaa T, Liu J, Voutilainen R: Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J Clin Endocrinol Metab 2002;87:4257-4263.
18. Bouraïma H, Lireux B, Mittre H, Benhaim A, Herrou M, Mahoudeau J, Guillon-Metz F, Kottler ML, Reznik Y: Major hyperestrogenism in a feminizing adrenocortical adenoma despite a moderate overexprression of the aromatase enzyme. Eur J Endocrinol 2003;148:457-461.
19. Illingworth PJ, Groome NP, Byrd W, Rainey WE, McNeilly AS, Mather JP, Bremner WJ: Inhibin-B: likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996;81:1321-1325.